23 Jan 2023 --- Symrise has reported double-digit organic growth of 11.4% in a year marked by multiple investments, a business restructuring and sales growth, as the company has reaped the benefits of increased out-of-home consumption. However, it anticipates lower consolidated key figures than expected for the past 2022 fiscal year. The primary reason for this is an impairment loss of €126 million (US$137 million) relating to the interest in Swedencare AB, a leading manufacturer of premium products for pets, which Symrise recognized in the fourth quarter.
